Table 3.
Group A (N = 43) |
Group B (N = 160) |
P-value | |
---|---|---|---|
Hepatic artery stenosis—n (%) | 2 (4.6) | 5 (3.1) | 0.64 |
Hepatic artery thrombosis—n (%) | 1 (2.3) | 0 | 0.21 |
ALT (U/L), mean ± SD | 878.77 ± 707.23 | 669.87 ± 703.71 | 0.08 |
AST (U/L), mean ± SD | 2,270.51 ± 1,698.15 | 1,563.66 ± 1,436.76 | 0.01 |
Delayed graft function—n (%) | 2 (4.6) | 3 (1.9) | 0.28 |
Hepatic artery-related bile duct stricture—n (%) | 3 (7.0) | 7 (4.4) | 0.44 |
Reoperation to stop bleeding—n (%) | 2 (4.6) | 3 (1.9) | 0.28 |
Aneurysm—n (%) | 0 | 0 | |
Primary non-function—n (%) | 0 | 0 |
ALT, alanine aminotransferase; AST, aspartate aminotransferase.